Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CVB Financial | CVBF | May 17, 2024 | 17.43 | +0.58 |
CVD Equipment | CVV | May 17, 2024 | 4.40 | -4.35 |
CVR Energy | CVI | May 17, 2024 | 29.60 | +1.23 |
Cvr Partners LP Unit | UAN | May 17, 2024 | 85.52 | +2.42 |
CVRx | CVRX | May 17, 2024 | 8.29 | +2.60 |
CVS Health | CVS | May 17, 2024 | 57.68 | +0.28 |
CXApp A | CXAI | May 17, 2024 | 3.06 | -4.38 |
CyberArk Software | CYBR | May 17, 2024 | 246.33 | +0.65 |
Cybin | CYBN | May 17, 2024 | 0.35 | -0.57 |
Cyclacel Pharmaceuticals | CYCC | May 17, 2024 | 2.29 | -2.14 |
Cyclacel Pharmaceuticals Pref | CYCCP | May 17, 2024 | 6.70 | 0.00 |
Cyclerion Therapeutics | CYCN | May 17, 2024 | 2.85 | 0.00 |
Cyclo Therapeutics | CYTH | May 17, 2024 | 1.40 | +2.19 |
Cyngn | CYN | May 17, 2024 | 0.12 | -7.30 |
Cytek Biosciences | CTKB | May 17, 2024 | 6.10 | -1.29 |
Cytokinetics | CYTK | May 17, 2024 | 59.53 | -0.65 |
Cytomed Therapeutics | GDTC | May 17, 2024 | 2.12 | -0.47 |
CytomX Therapeutics | CTMX | May 17, 2024 | 1.89 | -5.50 |
Cytosorbents | CTSO | May 17, 2024 | 0.97 | +11.69 |
D-MARKET Electronic Services & Trading ADR | HEPS | May 17, 2024 | 1.68 | +3.70 |
D-Wave Quantum | QBTS | May 17, 2024 | 1.30 | +0.78 |
D.R. Horton | DHI | May 17, 2024 | 151.50 | +0.35 |
Dada Nexus ADR | DADA | May 17, 2024 | 1.93 | +6.04 |
Daily Journal | DJCO | May 17, 2024 | 390.90 | +1.24 |
Dakota Gold | DC | May 17, 2024 | 3.00 | -0.33 |
Daktronics | DAKT | May 17, 2024 | 11.41 | -2.06 |
DallasNews A | DALN | May 17, 2024 | 3.76 | +2.31 |
Dana | DAN | May 17, 2024 | 14.03 | -0.64 |
Danaher | DHR | May 17, 2024 | 265.80 | +0.36 |
Danaos | DAC | May 17, 2024 | 85.15 | -0.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.